Pfizer Inc (NYSE:PFE), an American multinational Pharmaceutical company headquartered in New York, announced on Thursday that its board of directors has declared a USD0.38 per share fourth-quarter 2020 dividend on the company's common stock.
The dividend is payable 1 December 2020, to holders of the Common Stock of record at the close of business on 6 November 2020.
The fourth-quarter 2020 cash dividend will be the 328th consecutive quarterly dividend paid by Pfizer.
Ridgetech reports financial results for fiscal year to March 2026
AMGEN announces Q3 2026 dividend
West Pharmaceutical Services declares quarterly dividend of USD0.22 per share
MedPal AI acquires eMARx to expand digital care home platform
Valerio Therapeutics signs R&D collaboration with Abivax and outlines pipeline milestones
Labcorp declares quarterly dividend of USD0.72 per share
Aptamer Group launches Optimer-based Ebola diagnostic programme
SK bioscience to lead Gates Foundation-funded ROTOR project
Nona Biosciences and Lonza collaborate on antibody-based BBB-crossing technology for CNS diseases